A. Roszak

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

Kathleen N. Moore, Antoine Angelergues, Gottfried E. Konecny et al. · New England Journal of Medicine · 2023 · 316 citations · Full text

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer

Gerald S. Falchook, Robert L. Coleman, A. Roszak et al. · JAMA Oncology · 2018 · 88 citations · Full text

Involvement of toll-like receptor 9 polymorphism in cervical cancer development

A. Roszak, Margarita Lianeri, Anna Sowińska et al. · Molecular Biology Reports · 2012 · 85 citations · Full text

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

J.M. del Campo, A. Roszak, Mariusz Bidziński et al. · Annals of Oncology · 2009 · 66 citations · Full text

Phase Ii, Advanced Ovarian Cancer, Medicine +8

Effect of physical activity on bone strength and body composition in breast cancer premenopausal women during endocrine therapy.

Katarzyna Hojan, Piotr Milecki, Marta Molińska-Glura et al. · PubMed · 2013 · 50 citations